Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
50.0%
% of PPH's 27 holdings also in XPH
32.4%
% of XPH's 40 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 6.1% | 5.6% | 5.6% |
|
ZOETIS INC | 4.6% | 4.8% | 4.6% |
|
VIATRIS, INC. | 4.2% | 4.5% | 4.2% |
|
MERCK & CO. INC. | 4.6% | 4.2% | 4.2% |
|
JOHNSON & JOHNSON | 4.7% | 4.0% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XPH
 |
TEVA PHARMACEUTICAL-SP ADR | 5.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.6% |
|
ABBVIE INC | 5.2% |
 |
SANOFI-AVENTIS-ADR | 5.0% |
 |
NOVARTIS AG-ADR | 4.9% |
|
MCKESSON CORP | 4.6% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.6% |
|
ASTRAZENECA PLC-SPONS ADR | 4.3% |
|
AMERISOURCEBERGEN CORP | 4.3% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.3% |
PPH Underweight Relative to XPH
|
REATA PHARMACEUTICALS, INC. CLASS A | -7.9% |
|
AXSOME THERAPEUTICS, INC. | -4.4% |
|
ELANCO ANIMAL HEALTH, INC. | -3.8% |
|
ROYALTY PHARMA PLC CLASS A | -3.7% |
|
INTRA-CELLULAR THERAPIES INC | -3.6% |
|
VENTYX BIOSCIENCES, INC. | -3.0% |
|
CATALENT INC | -2.7% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.3% |
|
CORCEPT THERAPEUTICS INC | -2.2% |
|
CYMABAY THERAPEUTICS, INC. | -2.1% |